NCT05403723 2026-02-19Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLCUniversity of Maryland, BaltimorePhase 1 Suspended50 enrolled
NCT02815592 2024-09-04Trial of BMS-986012 in Combination With Platinum and EtoposideBristol-Myers SquibbPhase 1 Completed12 enrolled